This is a $75,000.00 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to the Regents of the University of Michigan. The contract does not have a set-aside designation. The University of Michigan is a leading public research institution that has previously held prime and subcontract awards with various federal agencies, including the Department of Veterans Affairs, to provide...
<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, has awarded a $27,000 firm-fixed-price purchase order contract to the Massachusetts Institute of Technology (MIT) for MWORKS CONSULTING & DEVELOPMENT services. The contract period of performance is from September 20, 2024 to March 19, 2025, with a final completion date of March 19, 2025. This contract does not have a set-aside designation.</p>
The U.S. Food and Drug Administration (FDA) awarded a $2,235,290.00 Firm Fixed Price definitive contract to the Regents of the University of Michigan (doing business as the University of Michigan) to conduct a study on "A MOSAIC APPROACH FOR UNDERSTANDING STIMULANT AND OPIOID USE AND USE DISORDER TRAJECTORIES AND ASSOCIATED CONSEQUENCES IN US ADULTS". The contract has an ultimate completion date of September 29, 2028 and was awarded on September 12, 2024. This contract was not...
This is a $49,998.42 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Bar-Haim Yair, a non-profit organization located in Rockville, Maryland. The contract has an ultimate completion date of June 4, 2025 and was awarded on July 3, 2023. The contract does not have a set-aside designation. Based on the agency, this contract is likely related to the National Institute on Drug Abuse's research and programmatic initiatives focused...
This is a cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Virginia Commonwealth University (VCU) for $11,354,157.46. The contract is for preclinical medication discovery and abuse liability testing services in support of NIDA's mission. The contract has a period of performance from February 22, 2017 to February 21, 2018, with a potential completion date of February 16, 2025. This award is not...
This is a $20,246,653 definitive cost-no-fee contract awarded by the National Institute on Drug Abuse (NIDA) to The McLean Hospital Corporation to assess potential substance abuse treatment medications using non-human primate models. The contract does not have a set-aside designation. The contract supports NIDA's Addiction Treatment Discovery Program (ATDP), which evaluates compounds for their potential to treat drug addiction by assessing effects on drug discrimination, self-administration, and...
This is a $5,880,561.15 definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Fredrick-Bizzell JV Partners LLC, a small disadvantaged business joint venture. The contract supports NIDA's Clinical Trials Network Dissemination Initiative, which aims to disseminate NIDA's substance use disorder research findings to treatment providers through activities such as symposia, workshops, expert panels, and online...
This is a $1,484,606.68 definitive contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan to conduct research and analysis on stimulant use, misuse, and use disorder trajectories. The contract has no set-aside designation. Under the contract, the University of Michigan will coordinate with Massachusetts General Hospital and Texas State University to supplement existing drug use and health survey data with clinical data from the MGH's HEAL project....
This is a $1,463,472.00 cost-plus-fixed-fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Medispin Inc. for research and development in mathematics and computer science. The contract has no set-aside designation and was awarded on September 30, 2004 with a completion date of September 25, 2012. As NIDA is the primary federal agency responsible for conducting and supporting research on the causes, consequences, prevention, and treatment of...
This federal contract award, identified as 00278200208D278022006, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Regents of the University of California (a child company of the State of California Controller's Office) as the prime contractor. The contract, which is a definitive contract with cost-no-fee pricing, has a ceiling value of $524,989.00 and is not set aside. The award supports research and development (R&D) and management support activities...
This is a $34,987,502.00 definitive cost-no-fee contract awarded by the National Institute on Drug Abuse (NIDA) to the Regents of the University of Michigan for the National Addiction and HIV Data Archive Program (NAHDAP). The contract has a performance period from April 1, 2024 to March 31, 2029. NAHDAP was established in 2009 to facilitate the sharing of social and behavioral science data related to drug addiction and HIV. The contract requires the University of Michigan to develop, maintain, and expand the NAHDAP data infrastructure and provide technical assistance to researchers depositing and accessing data. There is no set-aside designation for this contract. The University of Michigan has extensive experience in data archiving, data management, and providing research support services to federal agencies across scientific and medical domains.